Conference Coverage
Latest Content
Jul 25, 2026 | News
Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%
How Portable Oxygen Is Changing Home Respiratory Care: Doug Francis
Jul 24, 2026
Health Equity & Access Weekly Roundup: July 24, 2026
Jul 24, 2026
Polygenic Risk Scores Move Closer to IPF Clinical Use: David Zhang, MD
Jul 24, 2026
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
Jul 24, 2026
Advertisement
Shorts
0:55
CD19, a Smart Target With a Trade-Off: Martin Schrappe, MD, PhD
5 hours ago
by
Maggie L. Shaw(+1 more)
0:32
How SkinIO's Full Body Scan Caught Melanoma: Steve Bonner
2 days ago
by
Giuliana Grossi
0:29
The Importance of Context When Using Polygenic Risk Scores: David Zhang, MD
2 days ago
by
Sabrina McCrear(+1 more)
0:47
How ACOs Uncover Medicare "Mailbox Store" Fraud: Aisha T. Pittman, MPH
2 days ago
by
Pearl Steinzor(+1 more)
0:32
Paving the Way to a Myeloma Cure: Ajay K. Nooka, MD, PhD
2 days ago
by
Maggie L. Shaw(+1 more)
0:58
INCA033989 Marks a Potential Turning Point in Mutant Calreticulin–Positive Myelofibrosis: Claire Harrison, MD
3 days ago
by
Brooke McCormick(+1 more)
1:00
Why BMI Is Misleading for Measuring Cardiometabolic Risk: Deepak Bhatt, MD, MPH, MBA
4 days ago
by
Pearl Steinzor
1:27
Translated Financial Assistance Documents Are Critical to Reducing Care Barriers: Erin L. Duffy, PhD, MPH
9 days ago
by
Brooke McCormick(+1 more)
0:58
TED Approval Offers Bright Future for Treating Condition: Michael Yen, MD
9 days ago
by
Julia Bonavitacola(+1 more)
0:46
Supporting Families Requires Recognizing the Full Financial Impact of Pediatric Cancer: Cherie Daly, MD
12 days ago
by
Brooke McCormick(+1 more)
Personalized Expert Insights
Have a question about bispecific therapy? Connect with experts who have the answers.
A Conference You Don't Want To Miss
Two days of strategy, insights, and innovation in patient-centered oncology care. September 24–25.
Center on Health Equity & Access
Start seeing what truly shapes access and learn how you can redefine the landscape.
Stay Ahead of Clinical and Policy Change
AJMC's e-newsletter features payer-focused insights across priority disease areas.
Podcasts
Center on Health Equity & Access
Advertisement
All News
Advertisement
June 2026 brought 5 FDA firsts across infectious disease, oncology, and rare disease, expanding treatment options and addressing unmet patient needs.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Clesrovimab remained well tolerated through a second RSV season in infants at increased risk of severe RSV.
The Pharmacy Compounding Advisory Committee meets July 23-24 to discuss whether pharmacies may dispense BPC-157, TB-500, and 5 other peptides.
Dermatologists spend 13 hours weekly on prior authorization as health plans tout an 11% reduction in requests.
Use of automated insulin delivery technology improves a Healthcare Effectiveness Data and Information Set quality measure in individuals with type 2 diabetes.
Eplontersen added to standard of care did not significantly reduce cardiovascular death and recurrent events, a study finds.
Trump said imported generic drugs will face no tariff for 2 years starting August 1, then a 100% rate in 2028 and 200% in 2029, extending his trade fight to the drugs most Americans actually take.
New York City health officials confirmed a 5th fatality in the Upper East Side Legionnaires' disease outbreak.
This research reinforces that fixed-duration, chemotherapy-free regimens can offer both a tolerability and a patient-experience advantage over CIT.
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
How Portable Oxygen Is Changing Home Respiratory Care: Doug Francis
4
Obesity, Insulin Resistance, and the Silent Progression of MASH: A Hepatologist's Perspective
5